The Valley Desk

Clinical trial reportJournal of the European Academy of Dermatology and Venereology : JEADVPublished

Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study: An analysis with considerations for future studies

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Rowan-Virtua School of Osteopathic Medicine, with Rowan University linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of the European Academy of Dermatology and Venereology : JEADV
Published
Subject terms
Skin; Humans; Psoriasis; Treatment Outcome; Severity of Illness Index; Longitudinal Studies; Double-Blind Method; Antibodies, Monoclonal, Humanized
PubMed ID
37907280
Added to directory
Source checked

Report a correction or request removal